MAPS VACCINE Trademark

Trademark Overview

On Friday, January 25, 2019, a trademark application was filed for MAPS VACCINE with the United States Patent and Trademark Office. The USPTO has given the MAPS VACCINE trademark a serial number of 88985286. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 20, 2024. This trademark is owned by Affinivax, Inc.. The MAPS VACCINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein-based antigens; research and development in the field of vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens
maps vaccine

General Information

Serial Number88985286
Word MarkMAPS VACCINE
Filing DateFriday, January 25, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements

NOT AVAILABLE"VACCINE"
Goods and Servicesresearch and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein-based antigens; research and development in the field of vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, February 17, 2019
Primary Code042
First Use Anywhere DateThursday, October 30, 2014
First Use In Commerce DateMonday, January 9, 2023

Trademark Owner History

Party NameAffinivax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19808
Party NameAffinivax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02420

Trademark Events

Event DateEvent Description
Tuesday, April 9, 2019NON-FINAL ACTION WRITTEN
Tuesday, January 29, 2019NEW APPLICATION ENTERED
Sunday, February 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 8, 2019ASSIGNED TO EXAMINER
Tuesday, April 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 9, 2019NON-FINAL ACTION E-MAILED
Wednesday, October 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 16, 2019ASSIGNED TO LIE
Friday, October 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 7, 2019FINAL REFUSAL WRITTEN
Thursday, November 7, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, November 7, 2019FINAL REFUSAL E-MAILED
Wednesday, May 6, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, May 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 28, 2020SUSPENSION LETTER WRITTEN
Thursday, May 28, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 28, 2020LETTER OF SUSPENSION E-MAILED
Sunday, November 29, 2020ASSIGNED TO LIE
Monday, November 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 23, 2021SOU TEAS EXTENSION RECEIVED
Monday, August 23, 2021SOU EXTENSION 1 FILED
Monday, August 23, 2021SOU EXTENSION 1 GRANTED
Wednesday, August 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 10, 2022SOU TEAS EXTENSION RECEIVED
Monday, January 10, 2022SOU EXTENSION 2 FILED
Monday, January 10, 2022SOU EXTENSION 2 GRANTED
Wednesday, January 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 28, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 28, 2022SOU EXTENSION 3 FILED
Thursday, July 28, 2022SOU EXTENSION 3 GRANTED
Saturday, July 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 21, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, October 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 22, 2023SOU EXTENSION 4 FILED
Wednesday, February 22, 2023SOU EXTENSION 4 GRANTED
Friday, February 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 31, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 31, 2023SOU EXTENSION 5 FILED
Monday, September 11, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 11, 2023SOU EXTENSION 5 GRANTED
Tuesday, September 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023DIVISIONAL REQUEST RECEIVED
Friday, September 22, 2023USE AMENDMENT FILED
Friday, September 22, 2023TEAS STATEMENT OF USE RECEIVED
Friday, September 22, 2023TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, October 3, 2023DIVISIONAL PROCESSING COMPLETE
Tuesday, October 3, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, November 6, 2023SU - NON-FINAL ACTION - WRITTEN
Monday, November 6, 2023NON-FINAL ACTION E-MAILED
Monday, November 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, February 3, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Saturday, February 3, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, May 20, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 20, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Related Keywords

vaccine maps vaccines research field development antigens services comprising polysaccharide based immunotherapies